CVS HEALTH (CVS) DIvidends Date & History

Key Takeaways

• CVS Health pays an annualized dividend of $2.66 per share, or $0.665 quarterly, for a current yield of roughly 2.8%.
• The company has maintained its dividend for nearly three decades without a single cut, making it a reliable income source for long-term investors.
• Dividend growth has paused for ten consecutive quarters, with the last increase occurring in December 2023.
• The payout appears well covered by cash flow: free cash flow covered the dividend by roughly 2.3x in fiscal 2025.
• With a yield near the top of its industry, CVS appeals primarily to income-oriented and value-focused investors rather than aggressive dividend-growth seekers.

Dividend Overview

CVS Health Corporation, the healthcare services and pharmacy retail giant, pays a quarterly dividend of $0.665 per share, which annualizes to $2.66 per share. Based on recent trading levels, the dividend yield sits around 2.8%, placing it above the broader S&P 500 average and near the higher end of its own industry group. While the yield is respectable, CVS is best described not as a pure high-yield stock nor as a classic dividend-growth aristocrat, but rather as a steady, modest-yield dividend stock with a strong record of payment reliability. Income-focused investors have long viewed the payout as a central part of the investment thesis, particularly during periods when the share price has been rangebound. The dividend is declared and paid on a predictable quarterly schedule, providing consistent, recurring cash distributions to shareholders.

Dividend History and Growth

CVS Health has a long and stable dividend history, with payments maintained for nearly three decades and no cuts over that span. The annual dividend has grown from roughly $1.10 per share in 2015 to $2.66 today, reflecting a compound annual growth rate (CAGR) in the high single digits over that period. However, growth has been uneven in recent years. The company paused increases for several years following its acquisition of Aetna in order to prioritize debt reduction, then resumed raises before pausing again. The most recent increase took effect in December 2023, lifting the quarterly rate to $0.665. Since then, the dividend has been frozen for ten consecutive quarters as management works through a broader business turnaround. This pattern gives CVS a solid track record of consistency, but a modest and currently stalled growth profile.

Dividend Sustainability and Payout Ratio

The sustainability picture for CVS's dividend is generally favorable on a cash-flow basis. In fiscal 2025, the company generated about $10.64 billion in operating cash flow while paying roughly $3.40 billion in common dividends, an operating cash flow payout ratio near 32%. Free cash flow of approximately $7.8 billion covered the dividend by more than 2.3 times. Management has guided for at least $9.5 billion in operating cash flow in 2026, comfortably above the annualized payout. On an earnings basis, the trailing payout ratio appears elevated at roughly 70% to over 100% due to recent earnings pressure, though forward earnings estimates suggest a lower ratio ahead. The primary caution is balance-sheet leverage, with net debt around 3.2x EBITDA (a measure of earnings before interest, taxes, depreciation, and amortization), which is higher than peers and has contributed to the pause in increases.

Dividend Compared to Industry Peers

Within the managed-care and pharmacy space, CVS's dividend yield is comparatively attractive. Rival UNH (UnitedHealth Group) yields around 2.4% with a larger per-share dividend of $9.28 annually, while CVS's roughly 2.8% yield stands above it. WBA (Walgreens Boots Alliance) previously offered a high yield but suspended its payout, underscoring how CVS's uninterrupted payment record stands out. CVS's yield ranks in roughly the top quarter of its industry, though its dividend-growth streak and growth rate trail many large-cap healthcare peers. For investors weighing yield against growth, CVS offers more current income than UnitedHealth but less momentum in raising the payout, reflecting its higher leverage and ongoing turnaround priorities.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify dividend stocks, income-focused investments, trending names, breakout candidates, and emerging market opportunities far more efficiently than manual screening. To explore dividend payers and income opportunities alongside other market signals, visit the AI Screener.

Is This Stock Attractive for Dividend Investors?

CVS Health may appeal most to income-oriented and value-focused investors who prioritize a reliable, recurring cash payment over rapid dividend growth. The company's near-three-decade record without a cut, combined with a yield above the market average and strong free-cash-flow coverage, supports the case for conservative, long-term holders seeking steady distributions. Dividend-growth investors, by contrast, may find CVS less compelling given the multi-year freeze in increases and elevated leverage that has delayed further raises. Total-return investors should also weigh the company's ongoing operational turnaround and debt-reduction efforts against the income stream. Overall, CVS is best viewed as a stable-yield holding for patient investors comfortable with modest near-term dividend growth in exchange for an above-average payout and a long history of consistency.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations